Integral Health Asset Management, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Integral Health Asset Management, LLC reported 76 stock positions worth $1.0 billion. Its top holding was Tenet Healthcare (THC) at 4.4% of the portfolio, followed by Boston Scientific (BSX, 4.0%) and Viking Therapeutics (VKTX, 3.6%). Compared with Q4 2023, it opened 26 new positions, sold out of 17, added to 28 and reduced 17. The biggest buy was a new position in Merck (MRK) and the biggest sale an exit from Sanofi-ADR (SNY).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001773206
- Portfolio Value
- $1.0B (Q1 2024)
- SEC Filing
- 0001172661-24-002421 ↗ filed May 15, 2024
Holdings Value
Holdings 76 stocks · $1.0B
| THC Tenet Healthcare Corp. | 4.39% | 425,000 | $44.7M | Add +21.4% |
| BSX Boston Scientific Corp. | 4.03% | 600,000 | $41.1M | Add +60.0% |
| VKTX Viking Therapeutics Inc. | 3.62% | 450,000 | $36.9M | Reduce -10.0% |
| INSM Insmed Inc. | 3.46% | 1,300,000 | $35.3M | Add +271.4% |
| CYTK Cytokinetics Inc. | 3.10% | 450,000 | $31.5M | Add +125.0% |
| MRK Merck & Co. Inc. | 3.04% | 235,000 | $31.0M | New |
| EHC Encompass Health Corp. | 2.84% | 350,000 | $28.9M | Add +40.0% |
| WBA Walgreens Boots Alliance Inc. | 2.77% | 1,300,000 | $28.2M | Add +18.2% |
| ELV Elevance Health Inc. | 2.55% | 50,000 | $25.9M | Add +150.0% |
| ABBV Abbvie Inc. | 2.41% | 135,000 | $24.6M | Reduce -20.6% |
| UHS Universal Health Services-B | 2.24% | 125,000 | $22.8M | Add +78.6% |
| NVS Novartis AG-Sponsored ADR | 2.14% | 225,000 | $21.8M | No change |
| TARS Tarsus Pharmaceuticals Inc. | 2.11% | 590,000 | $21.4M | Add +490.0% |
| LBPH Longboard Pharmaceuticals Inc. | 2.07% | 975,000 | $21.1M | Add +8.3% |
| HUM Humana Inc. | 2.04% | 60,000 | $20.8M | New |
| NBIX Neurocrine Biosciences Inc. | 2.03% | 150,000 | $20.7M | Add +66.7% |
| BRKR Bruker Corp. | 2.03% | 220,000 | $20.7M | Add +120.0% |
| ISRG Intuitive Surgical Inc. | 1.96% | 50,000 | $20.0M | Add +25.0% |
| BPMC Blueprint Medicines Corp. | 1.96% | 210,000 | $19.9M | Add +50.0% |
| ACLX Arcellx Inc. | 1.74% | 255,000 | $17.7M | Add +59.4% |
| CRL Charles River Laboratories | 1.73% | 65,000 | $17.6M | No change |
| REGN Regeneron Pharmaceuticals | 1.61% | 17,000 | $16.4M | Reduce -32.0% |
| RGNX Regenxbio Inc. | 1.57% | 760,000 | $16.0M | Add +133.8% |
| PEN Penumbra Inc. | 1.53% | 70,000 | $15.6M | Add +75.0% |
| VERA Vera Therapeutics Inc. | 1.52% | 360,000 | $15.5M | New |
| CRNX Crinetics Pharmaceuticals Inc. | 1.49% | 325,000 | $15.2M | Add +62.5% |
| ICLR Icon PLC | 1.48% | 45,000 | $15.1M | Add +28.6% |
| CRSP Crispr Therapeutics AG | 1.47% | 220,000 | $15.0M | New |
| CI The Cigna Group | 1.43% | 40,000 | $14.5M | New |
| KRYS Krystal Biotech Inc. | 1.40% | 80,000 | $14.2M | Reduce -5.9% |
| DXCM Dexcom Inc. | 1.36% | 100,000 | $13.9M | Reduce -20.0% |
| RVMD Revolution Medicines Inc. | 1.33% | 420,000 | $13.5M | Add +110.0% |
| SWAV Shockwave Medical Inc. | 1.28% | 40,000 | $13.0M | New |
| AVTR Avantor Inc. | 1.25% | 500,000 | $12.8M | Add +150.0% |
| COR Cencora Inc. | 1.19% | 50,000 | $12.1M | Reduce -28.6% |
| TNYA Tenaya Therapeutics Inc. | 1.16% | 2,250,000 | $11.8M | New |
| COO The Cooper Cos Inc. | 1.10% | 110,000 | $11.2M | Reduce -21.4% |
| MLTX Moonlake Immunotherapeutics | 1.08% | 220,000 | $11.1M | No change |
| SANA Sana Biotechnology Inc. | 0.96% | 980,000 | $9.8M | New |
| NARI Inari Medical Inc. | 0.94% | 200,000 | $9.6M | Add +100.0% |
| LLY Eli Lilly & Co. | 0.92% | 12,000 | $9.3M | Reduce -57.1% |
| RGEN Repligen Corp. | 0.90% | 50,000 | $9.2M | Reduce -9.1% |
| ALPN Alpine Immune Sciences Inc. | 0.90% | 230,000 | $9.1M | New |
| ELAN Elanco Animal Health Inc. | 0.88% | 550,000 | $9.0M | Add +10.0% |
| APLS Apellis Pharmaceuticals Inc. | 0.87% | 150,000 | $8.8M | New |
| ITCI Intra-Cellular Therapies Inc. | 0.85% | 125,000 | $8.7M | Reduce -28.6% |
| EVH Evolent Health Inc. Class A | 0.80% | 250,000 | $8.2M | No change |
| TNDM Tandem Diabetes Care Inc. | 0.78% | 225,000 | $8.0M | New |
| FDMT 4D Molecular Therapeutics Inc. | 0.78% | 250,000 | $8.0M | Reduce -33.3% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.73% | 50,000 | $7.5M | Add +11.1% |
| OSCR Oscar Health Inc. Class A | 0.73% | 500,000 | $7.4M | New |
| MRUS Merus NV | 0.73% | 165,000 | $7.4M | New |
| MGNX Macrogenics Inc. | 0.72% | 500,000 | $7.4M | Add +11.1% |
| CABA Cabaletta Bio Inc. | 0.71% | 425,000 | $7.3M | Reduce -18.3% |
| INSP Inspire Medical Systems Inc. | 0.70% | 33,000 | $7.1M | Reduce -45.0% |
| ALKS Alkermes PLC | 0.66% | 250,000 | $6.8M | Add +0.4% |
| ROIV Roivant Sciences Ltd. | 0.62% | 600,000 | $6.3M | New |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 0.61% | 40,000 | $6.3M | New |
| RLAY Relay Therapeutics Inc. | 0.59% | 725,000 | $6.0M | Add +20.8% |
| SRRK Scholar Rock Holding Corp. | 0.57% | 325,000 | $5.8M | Add +225.0% |
| RVTY Revvity Inc. | 0.52% | 50,000 | $5.3M | New |
| ALGN Align Technology Inc. | 0.48% | 15,000 | $4.9M | Reduce -50.0% |
| NTRA Natera Inc. | 0.45% | 50,000 | $4.6M | Reduce -77.8% |
| LH Laboratory CRP of Amer Hldgs | 0.43% | 20,000 | $4.4M | Reduce -60.0% |
| A Agilent Technologies Inc. | 0.43% | 30,000 | $4.4M | New |
| SYRE Spyre Therapeutics Inc. | 0.37% | 100,000 | $3.8M | New |
| SAGE Sage Therapeutics Inc. | 0.37% | 200,000 | $3.7M | No change |
| ETNB 89BIO Inc. | 0.34% | 300,000 | $3.5M | New |
| EDIT Editas Medicine Inc. | 0.33% | 450,000 | $3.3M | New |
| AUTL Autolus Therapeutics PLC | 0.31% | 500,000 | $3.2M | New |
| MREO Mereo Biopharma Group PL-ADR | 0.31% | 950,000 | $3.1M | New |
| GH Guardant Health Inc. | 0.30% | 150,000 | $3.1M | New |
| APGE Apogee Therapeutics Inc. | 0.26% | 40,000 | $2.7M | New |
| KROS Keros Therapeutics Inc. | 0.26% | 40,000 | $2.6M | New |
| AXSM Axsome Therapeutics Inc. | 0.23% | 30,000 | $2.4M | New |
| FATE Fate Therapeutics Inc. | 0.14% | 200,000 | $1.5M | Reduce -77.8% |
Options reported separately and not counted above: VKTX puts ($24.6M), INSM calls ($13.6M), EXAS calls ($10.4M), MLTX calls ($10.0M).
Portfolio Sells Q4 2023 → Q1 2024
| SNY Sanofi-ADR | Sold out | 0.00% | −2.87 |
| TFX Teleflex Inc. | Sold out | 0.00% | −2.52 |
| ZBH Zimmer Biomet Holdings Inc. | Sold out | 0.00% | −1.76 |
| NTRA Natera Inc. | Reduce -77.8% | 0.45% | −1.59 |
| REGN Regeneron Pharmaceuticals | Reduce -32.0% | 1.61% | −1.56 |
| LLY Eli Lilly & Co. | Reduce -57.1% | 0.92% | −1.44 |
| MDT Medtronic PLC | Sold out | 0.00% | −1.43 |
| CNC Centene Corp. | Sold out | 0.00% | −1.39 |
| ABBV Abbvie Inc. | Reduce -20.6% | 2.41% | −1.39 |
| LH Laboratory CRP of Amer Hldgs | Reduce -60.0% | 0.43% | −1.21 |
| INSP Inspire Medical Systems Inc. | Reduce -45.0% | 0.70% | −1.07 |
| ARVN Arvinas Inc. | Sold out | 0.00% | −1.04 |
| HOLX Hologic Inc. | Sold out | 0.00% | −1.03 |
| ILMN Illumina Inc. | Sold out | 0.00% | −1.01 |
| CABA Cabaletta Bio Inc. | Reduce -18.3% | 0.71% | −0.99 |
| ITCI Intra-Cellular Therapies Inc. | Reduce -28.6% | 0.85% | −0.96 |
| SIBN Si-Bone Inc. | Sold out | 0.00% | −0.95 |
| COR Cencora Inc. | Reduce -28.6% | 1.19% | −0.88 |
| DXCM Dexcom Inc. | Reduce -20.0% | 1.36% | −0.88 |
| COO The Cooper Cos Inc. | Reduce -21.4% | 1.10% | −0.82 |
| ALGN Align Technology Inc. | Reduce -50.0% | 0.48% | −0.70 |
| AGL Agilon Health Inc. | Sold out | 0.00% | −0.59 |
| ACAD Acadia Pharmaceuticals Inc. | Sold out | 0.00% | −0.59 |
| RVNC Revance Therapeutics Inc. | Sold out | 0.00% | −0.57 |
| ZNTL Zentalis Pharmaceuticals Inc. | Sold out | 0.00% | −0.55 |
| RGEN Repligen Corp. | Reduce -9.1% | 0.90% | −0.53 |
| PDCO Patterson Cos Inc. | Sold out | 0.00% | −0.41 |
| FATE Fate Therapeutics Inc. | Reduce -77.8% | 0.14% | −0.34 |
| FDMT 4D Molecular Therapeutics Inc. | Reduce -33.3% | 0.78% | −0.32 |
| OGN Organon & Co. | Sold out | 0.00% | −0.31 |
| TDOC Teladoc Health Inc. | Sold out | 0.00% | −0.31 |
| VTYX Ventyx Biosciences Inc. | Sold out | 0.00% | −0.18 |
| KRYS Krystal Biotech Inc. | Reduce -5.9% | 1.40% | −0.13 |
| VKTX Viking Therapeutics Inc. | Reduce -10.0% | 3.62% | +2.28 |
Portfolio Buys Q4 2023 → Q1 2024
| MRK Merck & Co. Inc. | New | 3.04% | +3.04 |
| HUM Humana Inc. | New | 2.04% | +2.04 |
| INSM Insmed Inc. | Add +271.4% | 3.46% | +1.90 |
| TARS Tarsus Pharmaceuticals Inc. | Add +490.0% | 2.11% | +1.81 |
| VERA Vera Therapeutics Inc. | New | 1.52% | +1.52 |
| CRSP Crispr Therapeutics AG | New | 1.47% | +1.47 |
| CI The Cigna Group | New | 1.43% | +1.43 |
| LBPH Longboard Pharmaceuticals Inc. | Add +8.3% | 2.07% | +1.28 |
| SWAV Shockwave Medical Inc. | New | 1.28% | +1.28 |
| ELV Elevance Health Inc. | Add +150.0% | 2.55% | +1.18 |
| TNYA Tenaya Therapeutics Inc. | New | 1.16% | +1.16 |
| BRKR Bruker Corp. | Add +120.0% | 2.03% | +0.97 |
| SANA Sana Biotechnology Inc. | New | 0.96% | +0.96 |
| BSX Boston Scientific Corp. | Add +60.0% | 4.03% | +0.90 |
| ALPN Alpine Immune Sciences Inc. | New | 0.90% | +0.90 |
| APLS Apellis Pharmaceuticals Inc. | New | 0.87% | +0.87 |
| TNDM Tandem Diabetes Care Inc. | New | 0.78% | +0.78 |
| OSCR Oscar Health Inc. Class A | New | 0.73% | +0.73 |
| RGNX Regenxbio Inc. | Add +133.8% | 1.57% | +0.73 |
| MRUS Merus NV | New | 0.73% | +0.73 |
| UHS Universal Health Services-B | Add +78.6% | 2.24% | +0.70 |
| CYTK Cytokinetics Inc. | Add +125.0% | 3.10% | +0.69 |
| ROIV Roivant Sciences Ltd. | New | 0.62% | +0.62 |
| ONC Beone Medicines Ltd.-ADR | New | 0.61% | +0.61 |
| AVTR Avantor Inc. | Add +150.0% | 1.25% | +0.60 |
| THC Tenet Healthcare Corp. | Add +21.4% | 4.39% | +0.57 |
| RVTY Revvity Inc. | New | 0.52% | +0.52 |
| RVMD Revolution Medicines Inc. | Add +110.0% | 1.33% | +0.50 |
| CRNX Crinetics Pharmaceuticals Inc. | Add +62.5% | 1.49% | +0.47 |
| ACLX Arcellx Inc. | Add +59.4% | 1.74% | +0.46 |
| EHC Encompass Health Corp. | Add +40.0% | 2.84% | +0.43 |
| A Agilent Technologies Inc. | New | 0.43% | +0.43 |
| SYRE Spyre Therapeutics Inc. | New | 0.37% | +0.37 |
| ETNB 89BIO Inc. | New | 0.34% | +0.34 |
| EDIT Editas Medicine Inc. | New | 0.33% | +0.33 |
| NBIX Neurocrine Biosciences Inc. | Add +66.7% | 2.03% | +0.32 |
| AUTL Autolus Therapeutics PLC | New | 0.31% | +0.31 |
| MREO Mereo Biopharma Group PL-ADR | New | 0.31% | +0.31 |
| GH Guardant Health Inc. | New | 0.30% | +0.30 |
| SRRK Scholar Rock Holding Corp. | Add +225.0% | 0.57% | +0.30 |
| APGE Apogee Therapeutics Inc. | New | 0.26% | +0.26 |
| KROS Keros Therapeutics Inc. | New | 0.26% | +0.26 |
| AXSM Axsome Therapeutics Inc. | New | 0.23% | +0.23 |
| MGNX Macrogenics Inc. | Add +11.1% | 0.72% | +0.10 |
| BPMC Blueprint Medicines Corp. | Add +50.0% | 1.96% | +0.09 |
| PEN Penumbra Inc. | Add +75.0% | 1.53% | +0.08 |
| ICLR Icon PLC | Add +28.6% | 1.48% | +0.05 |
| ISRG Intuitive Surgical Inc. | Add +25.0% | 1.96% | +0.01 |
| NARI Inari Medical Inc. | Add +100.0% | 0.94% | +0.00 |
| ELAN Elanco Animal Health Inc. | Add +10.0% | 0.88% | −0.20 |
Options Activity Q4 2023 → Q1 2024
| CYTK Cytokinetics Inc. | call | Sold out | 400,000 | $33.4Mbefore exit |
| VKTX Viking Therapeutics Inc. | put | New | 300,000 | $24.6M |
| INSM Insmed Inc. | call | New | 500,000 | $13.6M |
| EXAS Exact Sciences Corp. | call | New | 150,000 | $10.4M |
| MLTX Moonlake Immunotherapeutics | call | New | 200,000 | $10.0M |
| CYTK Cytokinetics Inc. | put | Sold out | 100,000 | $8.3Mbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 89 | $2.4B | RVMD, INSM, CYTK, CVS, EWTX |
| Q1 2026 | 86 | $1.9B | INSM, RVMD, CYTK, REGN, VERA |
| Q4 2025 | 84 | $2.0B | INSM, RVMD, VERA, CYTK, REGN |
| Q3 2025 | 72 | $1.4B | INSM, CYTK, THC, MLYS, VERA |
| Q2 2025 | 70 | $1.1B | INSM, BSX, THC, EHC, MLYS |
| Q1 2025 | 76 | $902.7M | INSM, BSX, CYTK, THC, MLYS |
| Q4 2024 | 81 | $1.1B | INSM, THC, BSX, VERA, CYTK |
| Q3 2024 | 63 | $849.4M | INSM, THC, BSX, CYTK, LBPH |
| Q2 2024 | 69 | $1.0B | INSM, THC, CYTK, BSX, ELV |
| Q1 2024 | 76 | $1.0B | THC, BSX, VKTX, INSM, CYTK |